US › Healthcare

Vivos Therapeutics Inc (VVOS)

US · Healthcare · Medical Devices

$0.46+9.89%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$5.1M
Revenue YoY
+70.5%
Net profit
$-7.8M
Profit YoY
-100.6%
EPS
$-0.52
EPS estimate
$-0.45
Net margin
-150.8%

EPS came in at -0.52 against a street estimate of -0.45 — a miss of 15.6%.

Key statistics

Market cap
$5.7M
Forward P/E
0.0
P/B
6.86
Book value
$0.31
EPS (TTM)
$-2.14
52-week high
$5.21
52-week low
$0.36
50-day MA
$0.52
200-day MA
$1.43
Beta
6.12

Analyst view

Analysts rate Vivos Therapeutics Inc a buy (1 buy, 1 hold, 0 sell out of 2) with an average price target of $2.12.

Shareholding

Insiders
26.35%
Institutions
13.47%

Largest institutional holders

FundStake
Armistice Capital, LLC8.03%
Vanguard Capital Management, LLC1.97%
Geode Capital Management, LLC0.69%
Commonwealth Equity Services, LLC0.31%
IHT Wealth Management, LLC0.30%
National Asset Management Inc0.27%
Centurion Wealth Management LLC0.26%
Vanguard Fiduciary Trust Co0.22%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Vivos Therapeutics Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.